Evidence map›Paper›PMID 34367277›Full record

ArticleInternational journal of endocrinology2021

miR663 Prevents Epo Inhibition Caused by TNF-Alpha in Normoxia and Hypoxia.

Mete Ozkurt, Thomas Hellwig-Bürgel, Reinhard Depping, Selda Kadabere, Rumeysa Ozyurt, Abdullah Karadag, Nilüfer Erkasap

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Mete OzkurtDepartment of Physiology, Eskisehir Osmangazi University Medical Faculty, Eskisehir, Turkey.ORCID https://orcid.org/0000-0003-4000-2345
Thomas Hellwig-BürgelInstitute of Physiology, University of Lubeck, Lubeck, Germany.ORCID https://orcid.org/0000-0002-4007-6064
Reinhard DeppingInstitute of Physiology, University of Lubeck, Lubeck, Germany.ORCID https://orcid.org/0000-0002-4860-6058
Selda KadabereDepartment of Physiology, Eskisehir Osmangazi University Medical Faculty, Eskisehir, Turkey.ORCID https://orcid.org/0000-0002-9589-0063
Rumeysa OzyurtDepartment of Physiology, Eskisehir Osmangazi University Medical Faculty, Eskisehir, Turkey.ORCID https://orcid.org/0000-0002-9887-2645
Abdullah KaradagDepartment of Physiology, Adiyaman University Medical Faculty, Adiyaman, Turkey.ORCID https://orcid.org/0000-0003-3620-9589
Nilüfer ErkasapDepartment of Physiology, Eskisehir Osmangazi University Medical Faculty, Eskisehir, Turkey.ORCID https://orcid.org/0000-0002-2742-3519
Eskişehir Osmangazi University · TRUniversity of Lübeck · DEAdıyaman University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIn chronic inflammatory diseases, proinflammatory cytokines such as TNF-

methodsFirst, we determined the dose of TNF-

resultsAccording to our array study, TNF-

conclusionsmiR663 is involved in Epo mRNA production and that is able to prevent or reverse the inhibitory effect of TNF-

Identifiers

PMID34367277
PMCPMC8337158
OpenAlexW3185994955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.